Results 181 to 190 of about 74,294 (341)

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, Volume 100, Issue 5, Page 860-891, May 2025.
ABSTRACT Disease Overview Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments. Diagnosis, risk assessment, monitoring, and therapeutic management of AML have changed dramatically in the last decade due to increased pathophysiologic understanding, improved assessment technology, and the ...
Shai Shimony, Maximilian Stahl, Richard M. Stone   +2 more
wiley   +1 more source

Sequential high‐dose methotrexate and cytarabine administration improves outcomes in real‐world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance

eJHaem
Background Despite recent advances, optimal therapeutic approaches applicable to subpopulations with primary central nervous system (CNS) lymphoma outside of clinical trials remain to be determined.
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Li Mei Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia Ai, Ashley Beekman, Pietro R. Di Ciaccio, Michael Krigstein, Joel Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir‐Jing Ho, Tara Cochrane, Eliza A. Hawkes, Chan Y. Cheah, Stephen Opat, Gareth P. Gregory   +26 more
doaj   +1 more source

Varicella-Zoster Virus and Subcutaneous Cytarabine: Correlation of In Vitro Sensitivities to Blood Levels

, 1975
Dawlat A. Zaky, Robert F. Betts, R. Gordon Douglas, Kathleen Bengali, G L Neil   +4 more
openalex   +1 more source

Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine [PDF]

, 2000
David Sternberg, William C. Aird, Donna Neuberg, Lynn Thompson, Kimberly MacNeill, Philip C. Amrein, Lawrence N. Shulman   +6 more
openalex   +1 more source

The Roles of Exosomes in Anti‐Cancer Drugs

Cancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background Cancer is an escalating global health issue, with rising incidence rates annually. Chemotherapy, a primary cancer treatment, often exhibits low tumor‐targeting efficiency and severe side effects, limiting its effectiveness. Recent research indicates that exosomes, due to their immunogenicity and molecular delivery capabilities, hold
Panpan Feng, Xiaodong Zhang, Jian Gao, Lei Jiang, Yan Li   +4 more
wiley   +1 more source

A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation [PDF]

, 2001
Graham Jackson, P R Taylor, Graeme Smith, R. E. Marcus, Alastair G. Smith, Patrick Chu, Timothy J. Littlewood, Andrew Duncombe, Michael Hutchinson, Atul Mehta, S.A. Johnson, Peter Carey, M.J. Mackie, Peter Ganly, Gillian Turner, Miriam Deane, Steve Schey, Jonathan Brookes, Susan M. Tollerfield, Marcia Wilson   +19 more
openalex   +1 more source

The Clinical Safety and Efficacy of Cytarabine and Daunorubicin Liposome (CPX‐351) in Acute Myeloid Leukemia Patients: A Systematic Review

Cancer Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background Acute myeloid leukemia (AML) is an aggressive blood cancer with a poor prognosis when treated using conventional chemotherapy. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, has demonstrated potential as a novel therapeutic strategy.
Abdulwahab M. Alzahrani, Mohammed A. Alnuhait, Tariq Alqahtani   +2 more
wiley   +1 more source

A Rare Case of Langerhans Cell Histiocytosis in the Hard Palate

Turkish Journal of Hematology, 2022
Memiş Hilmi Atay, Seda Gün
doaj   +1 more source

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma [PDF]

, 2020
al., et, Bartlett, Nancy L., Cashen, Amanda, Edwin, Natasha, Ghobadi, Armin, Kahl, Brad, Mehta-Shah, Neha, Merryman, Reid W.   +7 more
core   +1 more source

Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia [PDF]

, 2001
Brynjar Foss, Elling Ulvestad, Tor Hervig, Øystein Bruserud   +3 more
openalex   +1 more source